Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Myomo, Inc. (MYO)

NYSE American - Nasdaq Real Time Price. Currency in USD
0.5001+0.0001 (+0.02%)
At close: 04:00PM EST
0.4857 -0.01 (-2.88%)
After hours: 05:55PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.5000
Open0.5000
Bid0.4851 x 800
Ask0.5100 x 1000
Day's Range0.4820 - 0.5096
52 Week Range0.3690 - 8.0750
Volume350,991
Avg. Volume1,202,316
Market Cap3.528M
Beta (5Y Monthly)1.07
PE Ratio (TTM)N/A
EPS (TTM)-3.6740
Earnings DateMar 07, 2023 - Mar 13, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.50
  • InvestorPlace

    7 Top Short-Squeeze Candidates to Watch in February

    While everyone knows that in order to have a market, there must be bulls and bears, that’s not going to stop people from attempting to garner intense profits from top short-squeeze candidates. To quickly summarize, shorting stocks involves borrowing shares to initiate the “negative” position. At some point, though, those borrowed shares must be returned. For the bears, they can be returned either at a profit or a loss. Now, in order to panic the bears into buying back their borrowed shares befor

  • Business Wire

    Myomo Appoints Yitzchak Jacobovitz to its Board of Directors

    BOSTON, January 30, 2023--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Yitzchak Jacobovitz as a Class II director effective January 27, 2023, to serve until the 2025 annual meeting of stockholders. With this appointment, Myomo has six directors.

  • Business Wire

    Myomo Announces Closing of $6.5 Million Upsized Public Offering

    BOSTON, January 17, 2023--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the closing of its previously announced "best efforts" public offering of 20,000,000 shares of common stock (or common stock equivalents in lieu thereof) at a public offering price of $0.325 per share for aggregate gross proceeds of approximately $6.5

Advertisement
Advertisement